Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Oversold Conditions For Corcept Therapeutics (CORT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

CORT : 24.41 (-1.49%)
Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles Robb Named Chief Business Officer

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

CORT : 24.41 (-1.49%)
Corcept (CORT) Q4 Earnings In Line, Revenues Miss Estimates

Corcept's (CORT) earnings meet estimates in the fourth quarter of 2020 while revenues miss the same.

PFE : 34.39 (+2.63%)
BMY : 60.75 (-0.85%)
CORT : 24.41 (-1.49%)
Corcept: 4Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Tuesday reported fourth-quarter profit of $26 million.

CORT : 24.41 (-1.49%)
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

CORT : 24.41 (-1.49%)
AMRX or CORT: Which Is the Better Value Stock Right Now?

AMRX vs. CORT: Which Stock Is the Better Value Option?

AMRX : 4.89 (-3.36%)
CORT : 24.41 (-1.49%)
Corcept (CORT) Posts Preliminary '20 Results, Gives 2021 View

Corcept (CORT) provides preliminary revenue figures for fourth-quarter and full-year 2020. The company also issues revenue guidance for 2021. Shares down in after-hours trading.

PFE : 34.39 (+2.63%)
MRK : 73.30 (+0.62%)
BMY : 60.75 (-0.85%)
CORT : 24.41 (-1.49%)
Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update

Financial Highlights, 2021 Revenue Guidance and Legal Update

CORT : 24.41 (-1.49%)
Corcept Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 8, 2021 / Corcept Therapeutics, Inc. (NASDAQ:CORT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 8, 2021...

CORT : 24.41 (-1.49%)
Why Corcept Therapeutics (CORT) Might Surprise This Earnings Season

Corcept Therapeutics (CORT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

CORT : 24.41 (-1.49%)
Corcept Therapeutics to Announce Preliminary Selected Financial Results, Provide Corporate Update and Host Conference Call

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report its preliminary 2020 fourth quarter and full-year financial results and provide a corporate update on February 8, 2021. The...

CORT : 24.41 (-1.49%)
Corcept (CORT) Up More Than 50% in Past 3 Months: Here's Why

Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. Other pipeline candidates are also advancing well.

PFE : 34.39 (+2.63%)
MRK : 73.30 (+0.62%)
BMY : 60.75 (-0.85%)
CORT : 24.41 (-1.49%)
Why Is Corcept (CORT) Up 25.8% Since Last Earnings Report?

Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CORT : 24.41 (-1.49%)
Corcept Therapeutics Appoints Gillian M. Cannon, PhD, to Board of Directors

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

MRK : 73.30 (+0.62%)
CORT : 24.41 (-1.49%)
L Brands, Sonos rise; United Airlines, Cubic fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially Thursday:

UAL : 54.57 (+2.56%)
SONO : 39.51 (-1.84%)
JACK : 99.47 (-5.09%)
NUAN : 43.14 (-3.08%)
CUB : 69.53 (+0.03%)
CORT : 24.41 (-1.49%)
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APVO, SOLO, AZN, CORT, and XXII.

XXII : 2.47 (-17.94%)
APVO : 33.98 (+0.98%)
AZN : 47.16 (-1.19%)
SOLO : 5.66 (-7.97%)
CORT : 24.41 (-1.49%)
U.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept's U.S. Patent No.10,195,214

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

CORT : 24.41 (-1.49%)
New Strong Sell Stocks for November 5th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

CORT : 24.41 (-1.49%)
ASC : 4.25 (+4.94%)
BWEN : 6.82 (-2.29%)
ALX : 282.90 (+2.87%)
EIDX : 122.21 (-4.85%)
Corcept (CORT) Misses on Q3 Earnings, Tightens 2020 Sales View

Corcept's (CORT) earnings and revenues fall shy of estimates in the third quarter of 2020. The company tapers its revenue guidance for the year. Shares fall in after-hours trading.

ENDP : 6.85 (-5.26%)
MRK : 73.30 (+0.62%)
BMY : 60.75 (-0.85%)
CORT : 24.41 (-1.49%)
Corcept Therapeutics (CORT) Lags Q3 Earnings and Revenue Estimates

Corcept (CORT) delivered earnings and revenue surprises of -19.05% and -4.23%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

CORT : 24.41 (-1.49%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar